OQS
MNOV icon

Occudo Quantitative Strategies’s MediciNova MNOV Stock Holding History

Occudo Quantitative Strategies’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,988
Closed -$51K – 1248
2021
Q4 		$51K Sell
18,988
-821
-4% -$2.74K ﹤0.01% 1008
2021
Q3 		$75K Sell
19,809
-68
-0.3% -$258 0.01% 941
2021
Q2 		$84K Buy
+19,877
New +$85.6K 0.01% 806

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Occudo Quantitative Strategies's MNOV Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of MediciNova (MNOV) in Q1 2022, closing a stake of 18,988 shares — an estimated $51K sold.

Occudo Quantitative Strategies first reported a position in MNOV in Q2 2021 and held it in 3 quarters. The position peaked at $84K in Q2 2021. 32 funds tracked by Wall St. Rank hold MNOV as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining MediciNova position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,988 MediciNova shares in Q1 2022, an estimated $51K.
  • Occudo Quantitative Strategies first reported a position in MediciNova in Q2 2021 and held it in 3 quarters.
  • Occudo Quantitative Strategies's MediciNova position peaked at $84K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held MediciNova as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.